论文部分内容阅读
目的分析厄贝沙坦与美托洛尔对慢性充血性心衰的治疗效果。方法将2012年2月-2015年3月期间收治于我院的慢性充血性心衰患者102例为研究对象,采用电脑数字随机分组方式将其均分成观察组51例以及对照组51例。其中对照组患者单纯采用厄贝沙坦治疗;观察组患者在对照组基础上加用美托洛尔。对两组患者的治疗效果进行比较分析。结果经过不同的治疗后,观察组患者的治疗总有效率为94.12%(48/51);对照组患者的治疗总有效率为82.35%(42/51),两组间比较差异显著(P<0.05),具备统计学意义。结论在对慢性充血性心衰患者进行治疗时,选择采用厄贝沙坦联合美托洛尔治疗可起到良好的治疗效果,对患者的临床症状起到良好的改善作用,可推广使用。
Objective To analyze the therapeutic effect of irbesartan and metoprolol on chronic congestive heart failure. Methods A total of 102 patients with chronic congestive heart failure admitted to our hospital from February 2012 to March 2015 were enrolled in this study. All patients were divided into observation group (n = 51) and control group (n = 51) by computer digital randomization method. The control group of patients treated with irbesartan alone; observation group patients in the control group based on the use of metoprolol. The treatment effect of two groups of patients were compared. Results After different treatments, the total effective rate of the observation group was 94.12% (48/51). The total effective rate of the control group was 82.35% (42/51), with significant difference between the two groups (P < 0.05), with statistical significance. Conclusion In the treatment of patients with chronic congestive heart failure, the choice of irbesartan combined with metoprolol therapy can play a good therapeutic effect, the clinical symptoms of patients play a good role in the improvement can be extended to use.